[PDF][PDF] Rhenium-188 (Sn) HEDP for treatment of osseous metastases

HR Maxon, LE Schroder, LC Washburn… - Journal of Nuclear …, 1998 - Soc Nuclear Med
Methods: It was evaluated by in vitro and in vivo testing in the laboratory, in animals and in
humans using 188Refrom a variety of sources. It may be produced by a desk-top method …

[PDF][PDF] Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases

JMH De Klerk, A Van Dijk… - Journal of nuclear …, 1992 - Soc Nuclear Med
METHODS Patients Eleven patients who suffered from metastatic bone pain were studied.
All patients had histopathologically proven breast (two patients, mean age: 47 yr) or prostate …

Rhenium-188-HEDP-kit formulation and quality control

ES Verdera, J Gaudiano, A Leon, G Martinez… - Radiochimica …, 1997 - degruyter.com
Summary, 88Re-HEDP has been prepared from lyophilized kits with 188Re from the
alumina 188W/188Re generator for evaluation for potential, cost-effective pain relief for …

[PDF][PDF] Rhenium-186 (Sn) HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo

HR Maxon, LE Schroder, VS Hertzberg… - Journal of Nuclear …, 1991 - Soc Nuclear Med
Study Design The resultsof our initial uncontrolled trial of a single intrave nous injection of
about 33 mCi (1,221 MBq) of †86Re (Sn) HEDP to each of 20 elderly men with advanced …

Rhenium-188 HEDP to treat painful bone metastases

S Li, J Liu, H Zhang, M Tian, J Wang… - Clinical nuclear …, 2001 - journals.lww.com
Purpose Rhenium-188 hydroxyethylidine diphosphonate (HEDP) is a new and attractive
radiopharmaceutical that localizes in skeletal metastases and emits beta particles that may …

Rhenium-188: availability from the 188W/188Re generator and status of current applications

M RA Pillai, A Dash, FF Knapp - Current radiopharmaceuticals, 2012 - ingentaconnect.com
Rhenium-188 is one of the most readily available generator derived and useful
radionuclides for therapy emitting β-particles (2.12 MeV, 71.1% and 1.965 MeV, 25.6%) and …

Rhenium-188-HEDP in the palliative treatment of bone metastases

K Liepe, R Hliscs, J Kropp, T Grüning… - Cancer Biotherapy …, 2000 - liebertpub.com
Introduction: Rhenium-188-HEDP (188Re-HEDP) is a new and attractive
radiopharmaceutical for the treatment of bone pain due to metastases. As a product of a …

Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer …

FF Knapp Jr, AL Beets, S Guhlke, PO Zamora… - Anticancer …, 1997 - europepmc.org
Rhenium-188 (beta-= 2.2 MeV; gamma= 155 keV; T1/2 16.9 hours) is an attractive
therapeutic radioisotope which is produced from decay of the reactor-produced tungsten …

Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases

WY Lin, CP Lin, SJ Yeh, BT Hsieh, ZT Tsai… - European journal of …, 1997 - Springer
The search for an ideal radioisotope for systemic radiotherapy continues. As a generator-
produced radioisotope emitting both beta and gamma rays and having a short physical half …

[CITATION][C] Dosage and response in radiopharmaceutical therapy of painful osseous metastases

EB Silberstein - Journal of Nuclear Medicine, 1996 - Soc Nuclear Med
For correspondence or reprints contact: EdWard B. Silberstein, MD, Eugene L Saenger
Radk@ sotopeLabo ratory, DMsenof NuclearMedidne, Departmentof Ra diology, University …